Eindhoven, Netherlands

Raffaella Rossin

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 76(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Journey of Raffaella Rossin

Introduction

Raffaella Rossin is a distinguished inventor based in Eindhoven, Netherlands, with an impressive portfolio of 10 patents. Her work primarily focuses on advancements in bio-orthogonal drug activation, showcasing her commitment to innovative solutions in the pharmaceutical field.

Latest Patents

Among her latest patents, Raffaella has developed a cleavable tetrazine used in bio-orthogonal drug activation. This invention demonstrates an advancement in provoked chemical cleavage, utilizing a diene as a chemically cleavable group attached to a construct. The process allows for the release of the construct through a reaction between the diene and a dienophile via an inverse electron demand Diels Alder reaction. Further, her innovation includes a kit designed for the release of a construct bound to a trigger, incorporating a tetrazine and a dienophile. Another significant patent involves a prodrug activation method utilizing abiotic reactive chemical groups exhibiting bio-orthogonal reactivity. Raffaella’s work in this area leads to the development of targeted therapeutics, particularly antibody-drug conjugates and bi- and trispecific antibody derivatives.

Career Highlights

Throughout her career, Raffaella has been associated with notable companies such as Tagworks Pharmaceuticals B.V. and Koninklijke Philips Corporation N.V. Her expertise and innovative mindset have positioned her at the forefront of drug development and chemical research.

Collaborations

Raffaella has collaborated with several talented individuals, including Marc Stefan Robillard and Ronny Mathieu Versteegen. These partnerships have enriched her work environment and fostered the exchange of ideas, further driving innovation in her field.

Conclusion

Raffaella Rossin's contributions to the field of bio-orthogonal drug activation exemplify her dedication to innovation. With a solid foundation of patents and valuable collaborations, she continues to be a leading figure in the realm of pharmaceutical research and development, paving the way for future advancements in targeted therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…